{"content":"<li class=\"n-box-item date-title\" data-end=\"1482901199\" data-start=\"1482814800\" data-txt=\"Sunday, December 22, 2019\">Tuesday, December 27, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3232603\" data-ts=\"1482882769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XGTI\" target=\"_blank\">XGTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232603-xg-technology-closes-10m-offering-for-acquisition-funds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XG Technology closes $10M offering for acquisition funds</a></h4><ul>   <li>XG Technology (<a href=\"https://seekingalpha.com/symbol/XGTI\" title=\"xG Technology, Inc.\">XGTI</a> <font color=\"red\">-6.1%</font>) has closed a $10M public offering that it will use toward a previously announced acquisition of Vislink Communications Systems.</li>    <li>XG sold 3.8M class A units (which each consisted of a share of common stock and 1.25 five-year warrants), along with 2,400 Class B units (each consisting of a share of Series E convertible preferred stock and a five-year warrant to buy 625 shares of common stock).</li>    <li>Class A units were priced at $2, while Class B units were priced at $1,000. Aegis Capital acted as sole book-runner.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232603\" data-linked=\"XG Technology closes $10M offering for acquisition funds\" data-tweet=\"$XGTI $XGTI-OLD - XG Technology closes $10M offering for acquisition funds https://seekingalpha.com/news/3232603-xg-technology-closes-10m-offering-for-acquisition-funds?source=tweet\" data-url=\"https://seekingalpha.com/news/3232603-xg-technology-closes-10m-offering-for-acquisition-funds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232601\" data-ts=\"1482881887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232601-morgan-stanley-sees-doctor-acceptance-for-portolas-betrixaban\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley sees doctor acceptance for Portola&#39;s betrixaban</a></h4><ul>   <li>Portola Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PTLA\" title=\"Portola Pharmaceuticals\">PTLA</a>) gave back some of Friday's <font color=\"green\">33% gain</font> as it came back from the holiday, <font color=\"red\">dropping 9.1%</font>.</li>    <li>The stock had moved up as the company's NDA for betrixaban was accepted for priority review by the FDA.</li>    <li>For one, Morgan Stanley thinks <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/12/8843342/physicians-likely-to-support-portolas-betrixaban\" target=\"_blank\">doctors will go for the anticoagualant</a>. \u201cWe continue to believe physicians are likely to support betrixaban given the unmet need in VTE prophylaxis, however, the statistical review is likely to be the greatest area of pushback,\u201d writes analyst Matthew Harrison.</li>    <li>But an advisory committee hearing will be key to shaping investor's views on the drug, intended for acutely ill patients with risk factors for venous thromboembolism.</li>    <li>Harrison has a rating of Overweight and a price target of $29, implying 27% upside from today's lower price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232601\" data-linked=\"Morgan Stanley sees doctor acceptance for Portola&#39;s betrixaban\" data-tweet=\"$PTLA - Morgan Stanley sees doctor acceptance for Portola&#39;s betrixaban https://seekingalpha.com/news/3232601-morgan-stanley-sees-doctor-acceptance-for-portolas-betrixaban?source=tweet\" data-url=\"https://seekingalpha.com/news/3232601-morgan-stanley-sees-doctor-acceptance-for-portolas-betrixaban\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232597\" data-ts=\"1482878181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232597-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/CEMP\" title=\"Cempra, Inc.\">CEMP</a> <font color=\"green\">+5.1%</font>. <a href=\"https://seekingalpha.com/symbol/BABA\" title=\"Alibaba Group Holding Limited\">BABA</a> <font color=\"green\">+3.7%</font>. <a href=\"https://seekingalpha.com/symbol/GLBL\" title=\"TerraForm Global\">GLBL</a> <font color=\"green\">+2.5%</font>. <a href=\"https://seekingalpha.com/symbol/BAS\" title=\"Basic Energy Services, Inc.\">BAS</a> <font color=\"green\">+2.2%</font>. <a href=\"https://seekingalpha.com/symbol/ALNY\" title=\"Alnylam Pharmaceuticals, Inc.\">ALNY</a> <font color=\"green\">+2.1%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/ENIC\" title=\"Enel Chile SA Sponsored ADR\">ENIC</a> <font color=\"red\">-1.8%</font>. <a href=\"https://seekingalpha.com/symbol/LL\" title=\"Lumber Liquidators Holdings, Inc.\">LL</a> <font color=\"red\">-1.6%</font>. <a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"red\">-1.6%</font>. <a href=\"https://seekingalpha.com/symbol/TS\" title=\"Tenaris S.A.\">TS</a> <font color=\"red\">-1.2%</font>. BBG <font color=\"red\">-1.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232597\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CEMP $BABA $GLBL - After Hours Gainers / Losers https://seekingalpha.com/news/3232597-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3232597-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232594\" data-ts=\"1482877138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232594-anthera-drops-66-sollpura-misses-study-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthera drops 66% as Sollpura misses study target</a></h4><ul>    <li>Anthera Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ANTH\" title=\"Anthera Pharmaceuticals, Inc.\">OTC:ANTH</a> <font color=\"green\">+2%</font>) has <font color=\"red\">slid 66%</font> after hours after its drug Sollpura missed  a primary endpoint in its Phase 3 SOLUTION study.</li>    <li>Results were encouraging and additional study is needed, the company said, but Sollpura missed its target for change of the coefficient of fat absorption non-inferiority margin.</li>    <li>The study examined the drug in cystic fibrosis patients with exocrine pancreatic insufficiency.</li>    <li>\"Given the robust activity\" of the drug in the context of the study, \"Anthera will initiate activities for an additional clinical study of Sollpura in patients with EPI due to Cystic Fibrosis, which Anthera expects will enable optimized dosing and dose titration.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232594\" data-linked=\"Anthera drops 66% as Sollpura misses study target\" data-tweet=\"$ANTH - Anthera drops 66% as Sollpura misses study target https://seekingalpha.com/news/3232594-anthera-drops-66-sollpura-misses-study-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3232594-anthera-drops-66-sollpura-misses-study-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232592\" data-ts=\"1482876177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VISN\" target=\"_blank\">VISN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232592-visionchina-media-posts-q3-results-cfo-resigns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VisionChina Media posts Q3 results; CFO resigns</a></h4><ul>   <li>VisionChina Media (<a href=\"https://seekingalpha.com/symbol/VISN\" title=\"VisionChina Media, Inc.\">VISN</a> <font color=\"green\">+21.7%</font>) rose today ahead of a news-filled <a href=\"https://seekingalpha.com/news/3232587-visionchina-media-reports-q3-results\" target=\"_blank\">Q3 earnings release</a> that featured the departure of its chief financial officer.</li>    <li>CFO Stanley Wang has resigned to pursue other opportunities; the company appointed its Controller Johnson Chau in the interim and will search for a successor.</li>    <li>In Q3, revenue from continuing operations rose 8.5% to $12.8M. The company swung to net income (diluted) of $0.19 per ADS from a year-ago loss of $0.98 per ADS.</li>    <li>Total broadcasting hours fell to 27,788 hours from a year-ago 32,340 hours. Total ad minutes on network were 102,523, down from 207,532 a year ago.</li>    <li>Average ad minutes per broadcast hour fell to 3.69 from 6.42; 144 advertisers bought time, vs. a year-ago 257.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3232592\" data-linked=\"VisionChina Media posts Q3 results; CFO resigns\" data-tweet=\"$VISN - VisionChina Media posts Q3 results; CFO resigns https://seekingalpha.com/news/3232592-visionchina-media-posts-q3-results-cfo-resigns?source=tweet\" data-url=\"https://seekingalpha.com/news/3232592-visionchina-media-posts-q3-results-cfo-resigns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232585\" data-ts=\"1482872578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSAT\" target=\"_blank\">GSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232585-globalstarminus-13-sets-call-to-discuss-fcc-order-on-tlps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globalstar -13%; sets call to discuss FCC order on TLPS</a></h4><ul>   <li>Globalstar (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/GSAT\" title=\"Globalstar, Inc.\">GSAT</a>) -- closing <font color=\"red\">down 13%</font> on the day after a <a href=\"https://seekingalpha.com/news/3232422-globalstar-moves-ahead-confirmed-tlps-approval\" target=\"_blank\">couple of strong sessions</a> -- has set a conference call to discuss the FCC's OK of its TLPS technology/service.</li>    <li>The company will hold a call Friday, Jan. 6 at 8:30 a.m. ET, which will feature prepared remarks and a Q&amp;A session.</li>    <li>CEO/Chairman Jay Monroe will take part, along with General Counsel Barbee Ponder; VP of Finance, Business Operations and Strategy Tim Taylor; and John Dooley, managing director at Jarvinian Ventures.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232585\" data-linked=\"Globalstar -13%; sets call to discuss FCC order on TLPS\" data-tweet=\"$GSAT - Globalstar -13%; sets call to discuss FCC order on TLPS https://seekingalpha.com/news/3232585-globalstarminus-13-sets-call-to-discuss-fcc-order-on-tlps?source=tweet\" data-url=\"https://seekingalpha.com/news/3232585-globalstarminus-13-sets-call-to-discuss-fcc-order-on-tlps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232581\" data-ts=\"1482871003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXS\" target=\"_blank\">AVXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232581-biogen-ionis-get-spinraza-boost-chardan-still-likes-avexis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen, Ionis get Spinraza boost; Chardan still likes AveXis</a></h4><ul>   <li>Biogen (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"green\">+1.5%</font>) and Ionis Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/IONS\" title=\"Ionis Pharmaceuticals, Inc.\">IONS</a> <font color=\"green\">+3.7%</font>) are higher in their first trading session since the <a href=\"https://seekingalpha.com/news/3232467-fda-oks-nusinersen-spinal-muscular-atrophy-ionis-pharma-3-percent-hours\" target=\"_blank\">FDA's approval</a> of Spinraza (nusinersen) for treating spinal muscular atrophy.</li>    <li>The moves are similar to after-hours trades on Friday. The news is also having its effect on competitor AveXis (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AVXS\" title=\"AveXis\">AVXS</a>), <font color=\"red\">down 5.9%</font> today.</li>    <li>But the market may be <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/12/8843052/why-the-biogen-ionis-news-is-a-boon-for-avexis\" target=\"_blank\">underestimating the potential</a> for AveXis' drug, says Chardan's Gbola Amusa, who has a Buy rating and $85 price target (implying 69% upside from today's now-lower price).</li>    <li>Spinraza (developed by Ionis and marketed by licensee Biogen) has a 23% death rate vs. 43% for untreated patients, but AveXis' AVXS-101 has a zero percent death rate, Amusa writes.</li>    <li>Despite study differences between the competitors, \"we believe the natural history of death for AVXS-101 patients, in a population group that is genotyped, suggests that AVXS-101 is a breakthrough therapy (as the probability of achieving AVXS-101\u2019s results may be 1 in 7.5 billion)\" and that the potential for lower death rates mean doctors and patients will choose it.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232581\" data-linked=\"Biogen, Ionis get Spinraza boost; Chardan still likes AveXis\" data-tweet=\"$AVXS $AVXS $BIIB - Biogen, Ionis get Spinraza boost; Chardan still likes AveXis https://seekingalpha.com/news/3232581-biogen-ionis-get-spinraza-boost-chardan-still-likes-avexis?source=tweet\" data-url=\"https://seekingalpha.com/news/3232581-biogen-ionis-get-spinraza-boost-chardan-still-likes-avexis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232579\" data-ts=\"1482869754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNC\" target=\"_blank\">GNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232579-in-new-pricing-landscape-gnc-closing-store-to-overhaul-labels\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In new pricing landscape, GNC closing store to overhaul labels</a></h4><ul>   <li>GNC (<a href=\"https://seekingalpha.com/symbol/GNC\" title=\"GNC Holdings, Inc.\">GNC</a> <font color=\"green\">+7.3%</font>) will work to revamp a confusing pricing model by <a href=\"http://www.wsj.com/articles/for-many-retailers-the-price-isnt-right-1482863716\" target=\"_blank\">closing all its stores Wednesday</a> for an overhaul, one of a number of retailers addressing a changing pricing landscape.</li>    <li>The vitamin/supplement store previously had as many as four prices on each label, depending on sales, promotions, and membership pricing. From here, the company plans to feature one price per product.</li>    <li>The move means that about half the company's products will start at prices lower than before, and a quarter will be higher. Discounts will still exist, but off of a much simpler base pricing model.</li>    <li>Other retailers, including Restoration Hardware; Bed, Bath and Beyond; and Abercrombie &amp; Fitch have struggled with pricing for loyalty/membership programs and couponing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232579\" data-linked=\"In new pricing landscape, GNC closing store to overhaul labels\" data-tweet=\"$GNC - In new pricing landscape, GNC closing store to overhaul labels https://seekingalpha.com/news/3232579-in-new-pricing-landscape-gnc-closing-store-to-overhaul-labels?source=tweet\" data-url=\"https://seekingalpha.com/news/3232579-in-new-pricing-landscape-gnc-closing-store-to-overhaul-labels\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232577\" data-ts=\"1482868808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232577-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> DRAM <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/FNCX' title='Function&#40;x&#41; Inc.'>OTC:FNCX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/KOPN' title='Kopin Corporation'>KOPN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-10%</font>. MSDI <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232577\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$USAU $FNCX $MVIS - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3232577-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232577-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232573\" data-ts=\"1482865436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232573-himax-technologies-introduces-image-sensor-targeting-next-generation-computer-vision\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax Technologies introduces image sensor targeting next-generation computer vision applications</a></h4><ul>\n<li>The HM5530 UltraSenseIR, low-power, low-noise, 5.5 megapixel back-illuminated CMOS image sensor with greater than 40% quantum efficiency in the near-infrared spectrum, is designed for 3D camera, autonomous navigation, event and pattern recognition, human-machine interaction, and other embedded computer vision implementations.</li>\n<li>Himax (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HIMX\" title=\"Himax Technologies, Inc.\">HIMX</a>) CTO Amit Mittra: \"Computer and machine vision devices operate unnoticed to human perception by using Near Infrared light sources and sensors because NIR is not visible to the human eye. Silicon based image sensor, which is the dominant technology for visual imaging applications due to advantages in cost, power and scalability, is not sensitive to the Near Infrared spectrum and needs to be compensated by using relatively large pixel sizes to confine the resolution of the sensor that can fit in an embedded device. With our breakthrough UltraSenseIR\u2122 technology, Himax combines the advantages of our highly integrated, low power and low noise BSI sensor technologies with NIR and visible sensitivity in a very small 2.0-micron pixel size to enable high resolution computer vision and NIR imaging applications.\"</li>\n<li>Shares <font color=\"green\">+4.19%</font> to $6.21.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232573\" data-linked=\"Himax Technologies introduces image sensor targeting next-generation computer vision applications\" data-tweet=\"$HIMX - Himax Technologies introduces image sensor targeting next-generation computer vision applications https://seekingalpha.com/news/3232573-himax-technologies-introduces-image-sensor-targeting-next-generation-computer-vision?source=tweet\" data-url=\"https://seekingalpha.com/news/3232573-himax-technologies-introduces-image-sensor-targeting-next-generation-computer-vision\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232574\" data-ts=\"1482865346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232574-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WRN' title='Western Copper and Gold Corporation'>WRN</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ASM' title='Avino Silver & Gold Mines Ltd'>ASM</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='red'>-12%</font>. SGY <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc'>UUUU</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232574\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$WRN $NAK $IPI - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3232574-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232574-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232571\" data-ts=\"1482864548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BZQIY\" target=\"_blank\">BZQIY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232571-bezeq-likely-heading-towards-ok-to-merge-business-units\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bezeq likely heading towards OK to merge its business units</a></h4><ul>   <li>Bezeq Israel (<a href=\"https://seekingalpha.com/symbol/BZQIY\" title=\"Bezeq The Israel Telecommunication Corp Ltd. ADR\">OTCPK:BZQIY</a> <font color=\"green\">+4.1%</font>) has gotten word that Israel's Communications Ministry is likely to <a href=\"http://www.reuters.com/article/us-israel-telecoms-bezeq-idUSKBN14E087?feedType=nl&amp;feedName=innovationNews&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=US%20Deals%20Today%202016-12-27&amp;utm_term=US%20Deals%20Today\" target=\"_blank\">allow the company to merge</a> its business units together.</li>    <li>That would end \"structural separation\" between mobile, fixed-line, satellite and Internet units -- and provide for Bezeq to offer multi-play packages, quickly becoming ubiquitous around the world.</li>    <li>Bezeq would likely need to commit to infrastructure investment and accelerating the spread of a fiber-optic broadband network over the next three years.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232571\" data-linked=\"Bezeq likely heading towards OK to merge its business units\" data-tweet=\"$BZQIY - Bezeq likely heading towards OK to merge its business units https://seekingalpha.com/news/3232571-bezeq-likely-heading-towards-ok-to-merge-business-units?source=tweet\" data-url=\"https://seekingalpha.com/news/3232571-bezeq-likely-heading-towards-ok-to-merge-business-units\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232569\" data-ts=\"1482862319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232569-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AAMC' title='Altisource Asset Management Corp'>AAMC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/LC' title='LendingClub Corporation'>LC</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SNFCA' title='Security National Financial Corporation'>SNFCA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/EVBN' title='Evans Bancorp, Inc.'>EVBN</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232569\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$AAMC $LC $SNFCA - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3232569-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232569-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232567\" data-ts=\"1482861837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232567-hulu-gets-exclusive-rights-to-dozens-of-older-disney-films\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hulu gets exclusive rights to dozens of older Disney films</a></h4><ul>   <li>Hulu has set a new multi-year deal to be the <a href=\"http://deadline.com/2016/12/hulu-show-50-disney-theatrical-movies-1201875948/\" target=\"_blank\">exclusive streaming home</a> of dozens of movies from the library of Walt Disney (<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a> <font color=\"green\">+0.2%</font>).</li>    <li>Disney -- a co-owner of Hulu along with Comcast (<a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a> <font color=\"green\">+0.4%</font>), Fox (<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Twenty-First Century Fox, Inc.\">FOX</a> <font color=\"green\">+0.3%</font>, <a href=\"https://seekingalpha.com/symbol/FOXA\" title=\"Twenty-First Century Fox, Inc.\">FOXA</a> <font color=\"green\">+0.2%</font>) and Time Warner (<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a> <font color=\"green\">+0.3%</font>) -- sends its new releases to Netflix (<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a> <font color=\"green\">+2.2%</font>), and it already supplies Hulu with made-for-TV content.</li>    <li>Now a chunk of older films will henceforth be found only on Hulu, including animated films <i>Mulan, Pocahontas, Hercules</i> and <i>The Nightmare Before Christmas</i> as well as movies like <i>Sister Act</i> (and several others to join later).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232567\" data-linked=\"Hulu gets exclusive rights to dozens of older Disney films\" data-tweet=\"$FOX $FOX $FOXA - Hulu gets exclusive rights to dozens of older Disney films https://seekingalpha.com/news/3232567-hulu-gets-exclusive-rights-to-dozens-of-older-disney-films?source=tweet\" data-url=\"https://seekingalpha.com/news/3232567-hulu-gets-exclusive-rights-to-dozens-of-older-disney-films\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232564\" data-ts=\"1482861096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232564-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/MBRX\" title=\"Moleculin Biotech, Inc.\">MBRX</a> <font color=\"green\">+42%</font>. <a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/VISN\" title=\"VisionChina Media, Inc.\">VISN</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/RADA\" title=\"Rada Electronics Industries Limited\">RADA</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/MVIS\" title=\"Microvision, Inc.\">MVIS</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/ENG\" title=\"ENGlobal Corporation\">ENG</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/NAK\" title=\"Northern Dynasty Minerals Ltd\">NAK</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/NL\" title=\"NL Industries Inc.\">NL</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/FNCX\" title=\"Function(x) Inc.\">OTC:FNCX</a> <font color=\"green\">+15%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a> <font color=\"red\">-20%</font>. <a href=\"https://seekingalpha.com/symbol/SGEN\" title=\"Seattle Genetics, Inc.\">SGEN</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/CO\" title=\"Global Cord Blood Corporation\">CO</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/PHMD\" title=\"PhotoMedex, Inc.\">PHMD</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/DPRX\" title=\"Dipexium Pharmaceuticals, LLC\">DPRX</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/GSAT\" title=\"Globalstar, Inc.\">GSAT</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/SYRS\" title=\"Syros Pharmaceuticals\">SYRS</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/ESES\" title=\"Eco-Stim Energy Solutions, Inc.\">ESES</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/CCRC\" title=\"China Customer Relations Centers Inc\">CCRC</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/HMNY\" title=\"Helios and Matheson Analytics, Inc.\">HMNY</a> <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232564\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$MBRX $CYCC $VISN - Midday Gainers / Losers https://seekingalpha.com/news/3232564-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3232564-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232558\" data-ts=\"1482858011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STLY\" target=\"_blank\">STLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232558-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li>Losers: <a href='https://seekingalpha.com/symbol/STLY' title='HG Holdings, Inc.'>OTC:STLY</a>&nbsp;<font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232558\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$STLY - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3232558-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3232558-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232552\" data-ts=\"1482854408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232552-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AAAP' title='Advanced Accelerator Applications'>AAAP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/APTO' title='Aptose Biosciences Inc.'>APTO</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CO' title='Global Cord Blood Corporation'>CO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals'>SYRS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar'>AMPH</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232552\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$MBRX $CYCC $TROV - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3232552-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3232552-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232550\" data-ts=\"1482853047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MVIS\" target=\"_blank\">MVIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232550-microvision-commences-shipments-of-small-form-factor-display-engine-samples\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MicroVision commences shipments of small form factor display engine samples</a></h4><ul>\n<li>Representing customer shipments that are on schedule, MicroVision is targeting Q2 2017 for mass production of its PSE-0403-101/2 engines.</li>\n<li>Samples of two additional scanning engines, one an interactive display engine supporting simultaneous projected display and multi-touch interactivity with projected images, and the other a sensing engine for mid-range LIDAR, are expected to begin shipping in Q2 and H2 2017, respectively, with production unit runs projected for Q3 2017 and H1 2018, respectively.</li>\n<li>MicroVision (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MVIS\" title=\"Microvision, Inc.\">MVIS</a>) <font color=\"green\">+11.42%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232550\" data-linked=\"MicroVision commences shipments of small form factor display engine samples\" data-tweet=\"$MVIS - MicroVision commences shipments of small form factor display engine samples https://seekingalpha.com/news/3232550-microvision-commences-shipments-of-small-form-factor-display-engine-samples?source=tweet\" data-url=\"https://seekingalpha.com/news/3232550-microvision-commences-shipments-of-small-form-factor-display-engine-samples\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232547\" data-ts=\"1482852065\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232547-endologixminus-21_9-holds-shipments-of-endovascular-device\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endologix -21.9% as it holds shipments of endovascular device</a></h4><ul>   <li>Shares in Endologix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a>) are cratering, now <font color=\"red\">down 21.9%</font>, after word it's placed a shipping hold on an endovascular device system to probe a manufacturing issue.</li>    <li>The company is holding shipments of its AFX Endovascular AAA System to look into issues with some sizes of the device.</li>    <li>Endologix stressed the \"proactive\" hold isn't related to any reported events from physicians. It added that the issue is unrelated to manufacturing its Nellix and Ovation, still available in approved markets.</li>    <li>After a brief update this morning, the company plans an update conference call planned to come by Friday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232547\" data-linked=\"Endologix -21.9% as it holds shipments of endovascular device\" data-tweet=\"$ELGX - Endologix -21.9% as it holds shipments of endovascular device https://seekingalpha.com/news/3232547-endologixminus-21_9-holds-shipments-of-endovascular-device?source=tweet\" data-url=\"https://seekingalpha.com/news/3232547-endologixminus-21_9-holds-shipments-of-endovascular-device\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232541\" data-ts=\"1482849511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESEA\" target=\"_blank\">ESEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232541-euroseasplus-8_5-on-fleet-renewal-moves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Euroseas +8.5% on fleet renewal moves</a></h4><ul>   <li>Euroseas (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ESEA\" title=\"Euroseas Ltd.\">ESEA</a>) is <font color=\"green\">up 8.5%</font> after word that it has taken delivery of a containership, and sold the oldest drybulk vessel in its fleet for scrap.</li>    <li>The company has received the M/V RT Dagr, a 1,645-TEU feeder containership built in 1998.</li>    <li>Euroseas bought RT Dagr by issuing 900,000 shares of stock. Meanwhile, the M/V Eleni P will be sold to scrap buyers in January 2017.</li>    <li>Overall, the move is a \"positive development\" for Euroseas and helps renew the fleet, says CEO Aristides Pittas. Following the moves (including previously announced acquisitions of the M/V Alexandros P and the M/V Capetan Tassos), the fleet will have 14 vessels, including eight feeder containerships.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232541\" data-linked=\"Euroseas +8.5% on fleet renewal moves\" data-tweet=\"$ESEA - Euroseas +8.5% on fleet renewal moves https://seekingalpha.com/news/3232541-euroseasplus-8_5-on-fleet-renewal-moves?source=tweet\" data-url=\"https://seekingalpha.com/news/3232541-euroseasplus-8_5-on-fleet-renewal-moves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232536\" data-ts=\"1482848709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSAT\" target=\"_blank\">GSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232536-globalstarminus-5_4-after-run-up-on-spectrum-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globalstar -5.4% after run-up on spectrum news</a></h4><ul>   <li>Shares in Globalstar (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/GSAT\" title=\"Globalstar, Inc.\">GSAT</a>) are trading <font color=\"red\">5.4% lower</font> premarket in some possible profit-taking after a couple of heady days following positive news at the FCC.</li>    <li>Word that the <a href=\"https://seekingalpha.com/news/3232205-globalstar-plus-20_4-percent-report-tlps-needed-fcc-votes\" target=\"_blank\">agency was approving</a> the company's Terrestrial Low Power Service sent Globalstar stock up nearly 30% over the past couple of trading days.</li>    <li>Shares have more than doubled over the past month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3232536\" data-linked=\"Globalstar -5.4% after run-up on spectrum news\" data-tweet=\"$GSAT - Globalstar -5.4% after run-up on spectrum news https://seekingalpha.com/news/3232536-globalstarminus-5_4-after-run-up-on-spectrum-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3232536-globalstarminus-5_4-after-run-up-on-spectrum-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232535\" data-ts=\"1482848487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232535-premarket-gainers-losers-of-9-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:15 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ESEA' title='Euroseas Ltd.'>ESEA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/INAP' title='Internap Network Services Corporation'>INAP</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3232535\" data-linked=\"Premarket Gainers / Losers as of 9:15 am\" data-tweet=\"$ESEA $IONS $ONVO - Premarket Gainers / Losers as of 9:15 am https://seekingalpha.com/news/3232535-premarket-gainers-losers-of-9-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3232535-premarket-gainers-losers-of-9-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232533\" data-ts=\"1482847848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDS\" target=\"_blank\">HDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232533-barrons-sees-upside-in-hd-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barron&#39;s sees upside in HD Supply</a></h4><ul>\n<li>HD Supply (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HDS\" title=\"HD Supply\">HDS</a>) is the subject of a positive <i>Barron's</i> profile, with the paper <a href=\"http://www.barrons.com/articles/hd-supply-is-set-to-build-on-recent-gains-1482555912\" target=\"_blank\">saying</a> the industrial products distributor could benefit from greater infrastructure spending and tax cuts.</li>\n<li>HDS <font color=\"green\">+2.5%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232533\" data-linked=\"Barron&#39;s sees upside in HD Supply\" data-tweet=\"$HDS - Barron&#39;s sees upside in HD Supply https://seekingalpha.com/news/3232533-barrons-sees-upside-in-hd-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/3232533-barrons-sees-upside-in-hd-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232532\" data-ts=\"1482847761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGEN\" target=\"_blank\">SGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232532-seattle-geneticsminus-14_6-pre-market-clinical-hold-set-on-multiple-vadastuximab-talirine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seattle Genetics -14.6% pre-market, clinical hold set on multiple vadastuximab talirine phase 1 trials</a></h4><ul>\n<li>The U.S. FDA notifies Seattle Genetics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SGEN\" title=\"Seattle Genetics, Inc.\">SGEN</a>) of several clinical or partial holds on the company's trials involving vadastuximab talirine (SGN-CD33A) in acute myeloid leukemia [AML], with evaluation of possible hepatotoxicity risks to patients treated with SGN-CD33A who received allogeneic stem cell transplants either prior to or after treatment cited as reasoning.</li>\n<li>Six patients with hepatotoxicity identified, inclusive of cases with veno-occlusive disease, with four fatal incidents noted.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232532\" data-linked=\"Seattle Genetics -14.6% pre-market, clinical hold set on multiple vadastuximab talirine phase 1 trials\" data-tweet=\"$SGEN - Seattle Genetics -14.6% pre-market, clinical hold set on multiple vadastuximab talirine phase 1 trials https://seekingalpha.com/news/3232532-seattle-geneticsminus-14_6-pre-market-clinical-hold-set-on-multiple-vadastuximab-talirine?source=tweet\" data-url=\"https://seekingalpha.com/news/3232532-seattle-geneticsminus-14_6-pre-market-clinical-hold-set-on-multiple-vadastuximab-talirine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3232525\" data-ts=\"1482844396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3232525-nvidia-on-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia on the move</a></h4><ul>\n<li>Nvidia (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a>) is <font color=\"green\">up 2%</font> in premarket trading, widening its already considerable lead as the best-performing Nasdaq 100 stock in 2016.</li>\n<li>Even after considerable gains this year, the company was <a href=\"https://seekingalpha.com/news/3231657-nvidia-added-conviction-buy-list-goldman-sachs\" target=\"_blank\">added</a> last week to the \"Conviction Buy\" list at Goldman Sachs.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3232525\" data-linked=\"Nvidia on the move\" data-tweet=\"$NVDA - Nvidia on the move https://seekingalpha.com/news/3232525-nvidia-on-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3232525-nvidia-on-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":25,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}